We offer our registered users tailored information, free online courses and exclusive content.
Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?
... or you lost your password?English
Meridiano Congress International (Italy)
Senior Project Manager: Concetta Di Palma
T +39 06 88 595 226 - F +39 06 88595 234
[email protected]
The registration fee is 225€ and includes:
• Access to scientific sessions
• Educational materials
• Certificate of attendance
• Coffee breaks and luncheon
Dinners are not included.
This programme is targeted at medical oncologists and radiation oncologists involved in the care of patients with advanced head & neck malignancies who wish to enhance their knowledge of clinical medicine and become aware of the latest advances in medical research.
Head and neck squamous cell carcinoma (HNSCC) is a group of extremely heterogeneous tumors. Surgery, radiation and chemotherapy in multiple combinations are used to manage HNSCC, depending on the TNM stage and primary site. The majority of patients present with locally advanced stage disease and require multimodal treatment. Managing HNSCC will likely to be subject to change in the near future, moving from treatment as a single disease to tailoring therapy based on both patient and tumour characteristics. This educational activity offers the chance to review treatment alternatives for head and neck cancer while illuminating emerging knowledge and controversy within the multidisciplinary management of locally advanced head and neck cancer patients. Concrete interaction between the multidisciplinary team and attendees will be supported through clinical case discussions and practical sessions focusing on treatment planning and delivery.
• Evaluate the benefit of multidisciplinary teams in the treatment of head and neck cancer
• Summarize general principles of surgery, radiotherapy and systemic therapies for the treatment of head and neck cancer patients
• Discuss how to optimize and refine therapeutic index in radiation therapy
An application will be made to the EACCME ® (European Committee for Continuing Medical Education) for CME accreditation of the EXCEMED “Practice teaching course on head and neck cancer management” to be held on 29-30 September 2017 in Saint- Priest en Jarez, France.
08.45 Opening and introduction
09.00 Visit of the lucien neuwirth cancer institute
N. Magné (France)
10.30 Coffee break
Lectures will be conducted by N. Magné (France)
11.00 L1: role of mDt and impact on therapeutic strategies
11.30 L2: multidisciplinary care in practice
12.00 L3: international guidelines for the treatment of hnscc
This lecture will be graphically recorded
12.40 L4: latest Breaking news in hnscc
J.-B. Guy (France)
13.00 Lunch
14.00 L5: Locally advanced hnscc
N. Magné (France)
14.40 i-solve clinical case interactive case solving
15.25 L6: recurrent/metastatic hnscc
N. Magné (France)
15:45 Coffee break
16.00 L7: optimize and refine therapeutic index in radiation therapy
C. Rancoule (France)
16.20 L8: management of radiation-related complications and supportive care
J.-B. Guy (France)
16.40 Ps: Practice session on toxicity management
This practice session will be graphically recorded
17.30 End of the first day
09.00 L9: the molecular biology of head and neck cancers
N. Magné (France)
09.30 L10: radiosensitivity and radioresistance of head and neck cancers: biological angle
C. Rancoule (France)
10.00 L11: targeting head and neck tumor stem cells to overcome resistance to therapy
A. Vallard (France)
10.45 Q&A
11.00 Coffee break
11.15 L12: overview on the current/open research programmes at the “radiobiologie cellulaire et moléculaire institut de Physique nucléaire de lyon”
J.-B. Guy (France)
12.15 Journal club
A. Vallard (France)
13.15 End of the course
Closing lunch
